Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
about
Cancer Immunoprevention and Public Health.Determination of factors predictive of outcome for patients undergoing a pancreaticoduodenectomy of pancreatic head ductal adenocarcinomas.Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma.The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection.Immunity Enhancement in Immunocompromised Gastrointestinal Cancer Patients with Allogeneic Umbilical Cord Blood Mononuclear Cell Transfusion.
P2860
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
@ast
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
@en
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
@nl
type
label
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
@ast
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
@en
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
@nl
prefLabel
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
@ast
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
@en
Immunodeficiency, immunosuppression, and susceptibility to neoplasms.
@nl
P1476
Immunodeficiency, immunosuppression, and susceptibility to neoplasms
@en
P2093
R S Schwartz
P356
10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A024257
P577
2001-01-01T00:00:00Z